Terry W. Lubben - 17 Sep 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
SVP, Operations
Signature
/s/ Jaime A. Frias as Attorney-in-fact for Terry W. Lubben
Issuer symbol
TMCI
Transactions as of
17 Sep 2021
Net transactions value
$0
Form type
4
Filing time
21 Sep 2021, 16:14:57 UTC
Next filing
10 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +135,000 $0.000000 135,000 17 Sep 2021 Common Stock 135,000 $28.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in equal annual installments over 4 years, commencing on September 17, 2022, with the last installment on September 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date.